Orexo AB Adjusts EBIT Expectations For Q4, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Uppsala, Sweden – December 20, 2013 – Orexo AB, “Orexo” (OTCQX: ORXOY; NASDAQ OMX Stockholm: ORX) announces adjustment to earlier communicated EBIT expectations for Q4 2013 with continuation of current conservative revenue recognition practise.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC